Human choriogonadotropin (hCG) is a heterodimeric hormone composed of an a and a (I subunit. hCG and its asialo (ashCG) and deglycosylated (dghCG) forms vary in their ability to stimulate hormone responsive adenylate cyclase. ashCG is a partial agonist, and dghCG is an antagonist. Photoactivatable moieties were coupled to hCG, ashCG, and dghCG, and the derivatives were radioiodinated. Competitive binding studies indicate that al of the derivatives had a similar affinity for the gonadotropin receptor on porcine granulosa cell membranes. Radiolabeled derivatives were used to photoaffmity label the gonadotropin receptor. Radiolabeled complexes were separated by NaDodSO4/PAGE. Al of the derivatives produced similar autoradiographic patterns, except that dghCG produced an additional 48-kDa complex. To investigate the structure of the complexes further, peptide mapping of proteolytic digests was used. All, except for the 48-kDa complex, generated similar peptide maps indicating a relationship between those complexes in which the smaller components are part of the larger. The 48-kDa complex contained both subunits of 40-kDa dghCG. Therefore, this complex is expected to contain an additional component of 8 kDa. The complex was generated whether the hormone-receptor complex was photoaffinity labeled on cells, on isolated membranes, or after solubilizing in detergent. Formation was blocked by excess hCG and did not occur in the absence of UV irradiation. We conclude that the hCG derivatives are able to photoaffinity label the hCG receptor but that the dghCG derivative can photoaffiity label an additional component that was not observed when derivatives of hCG or ashCG were used to label the receptor.
Pituitary lutropin and placental human choriogonadotropin (hCG) are heterodimeric glycoproteins that recognize the same receptor and elicit similar physiological responses. The amino acid sequence of the a and ,B subunits have been established, and the carbohydrate sequences have been determined (1) . Removal of terminal sialic acid residues does not interfere with receptor binding but results in a loss of in vivo, but not in vitro, biological activity (2, 3) . It has been reported that chemically deglycosylated hCG (dghCG) is an antagonist, failing to activate adenylate cyclase but binding with affinity similar to that of hCG (4) (5) (6) . Studies of this nature indicate that the carbohydrate moieties are not important for binding of the hormone but play a role in activation of the adenylate cyclase system. To investigate differences in the way hCG, the asialo derivative of hCG (ashCG), and dghCG interact with the receptor, we have made photoactivable derivatives and used them to label the gonadotropin receptor of porcine granulosa cells.
EXPERIMENTAL PROCEDURES
Preparation and Characterization of Hormone Derivatives. hCG, batch CR-123, was supplied by the Center for Population Research (National Institutes of Health and Human Development). The biological potency was 12,780 units/mg. ashCG and dghCG were prepared as described (5, 7) . The N-hydroxysuccinimide ester of 4-azidobenzoylglycine (ABG) was synthesized, and hormones (hCG, ashCG, and dghCG) were derivatized with the reagent and radioiodinated following reported procedures (8) . Competitive binding studies were done as reported (9) , except that the competitors were either unlabeled hCG or the corresponding unlabeled nonderivatized hormone analogue. ABG-hormone derivatives were also tested for their ability to stimulate adenylate cyclase. Murine Leydig tumor cell membranes were prepared (10) , and adenylate cyclase activity (11) was assayed as described.
Cell Preparation. Porcine ovaries, rich with large follicles but free of corpora lutea, were selected and rinsed with Medium 199. Follicles were excised (9) , and granulosa cells were collected in 80 ml of Medium 199 containing 1 mM phenylmethylsulfonyl fluoride, 20 uM tosyl-L-lysine chloromethyl ketone, 5 mM 6-amino caproic acid, 2 mM EDTA, 100 ,um benzamidine, leupeptin at 5 ,ug/ml, and pepstatin at 7 ,ug/ml. This combination represents inhibitors for all four major classes of proteases (serine, thiol, metallo-dependent, and carboxyl). These inhibitors were included in all buffers except that 6-amino caproic acid was deleted when samples were cross-linked and that all inhibitors were omitted for samples to be digested. It is important to prevent aggregation of cells by occasional, gentle mixing and by maintaining the cell concentration below 3 x 106 cells per ml and temperature below 4°C. Cells were collected by centrifugation at 600 x g for 10 min and rinsed twice in 15 To cleave cross-linked complexes resolved on first-dimension slab gels, gel lanes were cut and incubated for 90 min at 370C in the cleaving solution containing 0.1% NaDodSO4, 10 mM dithiothreitol, and 100 mM Na3PO4 (pH 11.5). The treated gel lanes were mounted on the top of fresh slab gels and subjected to a second electrophoresis.
RESULTS
Competitive binding of the ABG-and 1251-labeled derivatives of hCG, ashCG, and dghCG to their receptors in granulosa membranes was evaluated in the presence of increasing concentrations of hCG (Fig. 1 ) or in the presence of their respective unlabeled nonderivatized analogue (Fig. 1) . The _j equilibrium association constants for ashCG and dghCG binding to granulosa cells were slightly higher than that of hCG (Table 1) . These values also agree with those reported for binding of gonadotropins to their receptors in other systems (13) . Stimulation of adenylate cyclase by hCG and ashCG was also similar, but dghCG did not show any significant stimulation of the enzyme (Table 2) , similar to the findings of others (4-6).
The a subunits of 125I-labeled ashCG-ABG and 125I-labeled hCG-ABG were the primary sites for radioiodination, whereas in 125I-labeled dghCG-ABG the 13 subunit was radioiodinated in addition to the a subunit (Fig. 2) . The electrophoretic mobility of the subunits and the dimers increased in the order of hCG, ashCG, and dghCG, as expected, with removal of I Photoaffinity labeled hormone-receptor complexes resolved in one dimension by NaDodSO4/PAGE were subjected to proteolytic digestion, and the products were separated in a second dimension of NaDodSO4/PAGE (Fig. 4) . Peptide maps of complexes A-D were similar. The smallest radiolabeled peptide generated by protease treatment of these complexes (indicated by the arrows) had the same electrophoretic mobility but was different from the smallest peptide produced from the 48-kDa complex (Fig. 4, arrowheads) . This was true for both V8 protease and papain digestion.
To investigate the hormone subunit composition of the 48-kDa complex, we cross-linked 125I-labeled dghCG to its receptor on granulosa cells with SES. NaDodSO4/PAGE revealed that the cross-linker produced a 48-kDa band just as hCG-R 0 The samples were then subjected to proteolytic digestion with V8 protease or papain before separating by a second NaDodSO4/PAGE. The position of the smallest radiolabeled peptide fragment is designated by the arrows. Arrowheads indicate the peptide fragments appearing only with the 48-kDa complex (48k). The experiment was repeated five times, and the data presented here are representative of a typical experiment. the photoaffinity labeling procedure had. The cross-link was partially cleaved, and the products were separated in a second dimension by NaDodSO4/PAGE (Fig. 5) . By this technique we were able to identify a component with the same mobility as the a3 dimer of dghCG (Fig. 5) . In addition, the a subunit could be identified as a product ofcleavage. The sample photoaffinity labeled with the dghCG derivative showed a faint additional band slightly above band A (Figs.  2-4) . The identity of this complex is unknown.
DISCUSSION
Investigations have made it clear that dghCG binds specifically and with high affinity to the gonadotropin receptor; however, it does not activate adenylate cyclase (4-6). It is apparent that the sugar moieties are not important for the binding activity but are necessary for the biological activity. ashCG also binds with high affinity to the gonadotropin receptor. ashCG, which lacks only the sialic acid residues, is also an agonist, although it is less potent than native hCG (14) . Since dghCG is an antagonist, its binding to the gonadotropin receptor may not disturb the configuration of the unstimulated (basal) state of the hormone-responsive Cross-linked dghCG-receptor complex separated by NaDodSO4/PAGE. "'II-labeled dghCG was cross-linked to its receptor on granulosa cells with SES, and the complexes were separated by NaDodSO4/PAGE. The cross-links were then partially cleaved, and the products were separated by a second NaDodSO4/ PAGE. 48k, 48-kDa complex. adenylate cyclase system. By photoaffinity labeling the receptor with photoactivatable, radiolabeled hormone derivatives, we hoped to discover (i) if there is some portion of the receptor that can be labeled with hCG and ashCG but not with dghCG and, therefore, that may be implicated in activation of the adenylate cyclase system; and/or (ii) if some component associated with the receptor in the basal state, but not the activated state, could be photoaffinity labeled with dghCG but not with the agonists hCG or ashCG.
We have found that a number of high molecular weight complexes were generated by photoaffinity labeling of the gonadotropin receptor wih ABG-and '25I-labeled derivatives. In this report, we have designated them as complexes A-D for the purposes of identification. This suggests a heterooligomeric structure for the receptor, which agrees with previous reports (12, 15) . Some investigators have claimed that the heterooligomeric nature of the receptor is due to proteolytic degradation (16) and that in the absence of proteolysis the receptor is a single polypeptide chain. This is similar to the results of others that indicate that the gonadotropin receptor is a polypeptide with a molecular size of -90 kDa (10, 17, 18) . During this investigation we have been careful to avoid proteolysis by including protease inhibitors throughout the procedures. We cannot, however, completely eliminate the possibility of proteolytic degradation particularly before hormone binding.
In addition to components A-D, a 48-kDa complex was generated when 1251-labeled dghCG-ABG was used to photoaffinity label the gonadotropin receptor. Proteases were used to generate peptide maps of the complexes to understand their relationship to one another. V8-and papaingenerated peptide maps of photoaffinity-labeled complexes A-D were similar to each other. This was true regardless of which hormone derivative was used to form the complexes. Thus there is an apparent relationship between these components such that each successively smaller component is contained within the larger ones. However, the peptide map of the 48-kDa complex was different from that of the other photoaffinity-labeled complexes.
The molecular size of the 48-kDa complex was similar to that of the native hCG. We considered the possibility that the dghCG preparation was contaminated with hCG. We have investigated this possibility by extensively cross-linking the dghCG preparation and have failed to generate a complex of .4 v the same electrophoretic mobility. Thus the 48-kDa complex is likely to represent a complex composed of dghCG (or one of its subunits) and a component of the cell membrane.
The 48-kDa component may represent a receptor-hormone complex that contains only the dghCG /8 subunit. The (3 subunit of dghCG is unique in that it was radioiodinated, whereas (3 subunits of hCG and ashCG were virtually unlabeled (Figs. 2 and 3) . Thus it could be argued that the 48-kDa complex was present in all of the photoaffinitylabeled samples but appeared as a radioactive band only in the samples labeled by the dghCG derivative. This can be possible only if the 48-kDa complex is composed of the 3 subunit but not the a subunit. To determine which hormone subunits were contained in the 48-kDa complex, we first cross-linked 251I-labeled dghCG to its receptor and then located the complex on NaDodSO4/PAGE. Under the proper cleaving conditions some, but not all, of the cross-links can be broken with the result that a radiolabeled component having the same electrophoretic mobility as the ,a-3 dimer of dghCG appeared. In addition, if the 3 subunit were the only component of dghCG in the complex, it should be apparent in the cleaved products. This is not the case, and in fact the a subunit was detected. This result supports the hypothesis that the 48-kDa complex contains both subunits of dghCG and thus represents a complex not previously observed when hCG or ashCG is used in photoaffmity-labeling (or crosslinking) experiments. Therefore, we estimate that the 48-kDa complex contains an 8-kDa component in addition to the a-/3 dimer of 125I-labeled dghCG-ABG. A more direct way to test the hypothesis is to photoaffinity label the receptor with hCG that has the radioiodinated P subunit. Although the (3subunit in whole hCG is resistant to radioiodination, it can be radioiodinated after its dissociation from the a subunit. Such a radiolabeled 3 subunit can be recombined with an unlabeled a subunit. Results of such experiments (19) were inconsistent with the hypothesis, and no radioactive complex equivalent to the 48-kDa complex was produced.
The 8-kDa component may represent a component of the hCG receptor. It is also possible that it represents some component closely associated with the receptor but not a part of the receptor itself. This component may become dissociated from the receptor upon activation and hence it cannot be labeled with the agonists hCG or ashCG. If the 8-kDa component is not a part of the receptor, then it must necessarily be associated with it since photoaffinity labeling of the detergent solubilized dghCG-receptor complex also produced the 48-kDa complex. A potential candidate that would fit the criterion set forth for the 8-kDa component is the y subunit of the regulatory guanine nucleotide (G) binding protein of the adenylate cyclase system (20, 21) . The dghCG appears to have a direct access to the 8-kDa component. If this 8-kDa component is the y subunit (20) , our result suggests an intriguing possibility of the hormone's direct contact with the y subunit either at the cell surface and/or inside of cells, its cell surface exposure and the transmembrane nature of the regulatory subunit. In view of the potential regulatory interactions of hormone receptors with the ,Band y complex (20, 21) and the absence of a transmembrane domain in the y subunit (22) , it is possible that the /3 subunit could be a transmembrane polypeptide and responsible for anchoring the regulatory protein to cell membranes.
